Related Experiment Video
Updated: May 27, 2026

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
Normative axial length growth references in preterm and term infants for clinical use in early onset glaucoma
Sushmita Kaushik1, Pinkesh Dhariwal2, Poonam Verma2
1Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh, India sushmita_kaushik@yahoo.com.
Insights
Preterm infants show faster axial eye growth than term infants, necessitating specific references for early glaucoma detection. These findings aid in differentiating normal growth from pathological enlargement.
Area of Science:
- Ophthalmology
- Pediatrics
- Biometry
Background:
- Establishing normative ocular growth data is crucial for identifying deviations.
- Early-onset glaucoma requires precise monitoring tools, especially in vulnerable infant populations.
Purpose of the Study:
- To create normative axial length growth references for preterm infants (without retinopathy of prematurity) and term-born children under 5 years.
- To develop templates for evaluating and monitoring early-onset glaucoma.
Main Methods:
- Prospective cross-sectional study including preterm (<37 weeks GA) and term infants/children.
- Axial length measured via ultrasonic biometry.
- Growth references plotted against postmenstrual age (PMA) for preterm and months for term infants; statistical analysis of growth slopes and predictors.
Main Results:
- 220 eyes analyzed; preterm infants had smaller mean axial length (16.95±1.15 mm) than term infants (21.15±1.6 mm) at comparable ages.
- Postmenstrual age (PMA) and birth weight were significant predictors of axial length in preterm infants; PMA was the primary predictor in term infants.
- Preterm eyes exhibited a significantly steeper axial elongation slope (0.16) compared to term eyes (0.02).
Conclusions:
- Steeper axial elongation in preterm infants may indicate compensatory growth and is vital for glaucoma assessment.
- Developed growth references serve as practical tools to differentiate physiological ocular growth from pathological enlargement in neonatal-onset glaucoma.
Purpose:
To establish normative axial length growth references for preterm infants without retinopathy of prematurity (ROP) and term-born children under 5 years and construct templates to aid early-onset glaucoma evaluation and monitoring.
Methods:
In this prospective cross-sectional study, preterm infants (<37 weeks' gestational age) without ROP and healthy term-born children under 5 years were included. Axial length was measured using ultrasonic biometry. Growth references were plotted on logarithmic scales: postmenstrual age (PMA) for preterm infants, months for term children. Analysis of covariance compared the growth slopes. Multiple linear regression assessed predictors of axial length growth (gestational age, measurement age and birth weight).
Results:
220 eyes (101 term, 119 preterm) were analysed. The mean gestational age was 39.5±0.84 weeks in term and 31.8±2.17 weeks in preterm infants. The mean axial length was 21.15±1.6 mm in term and 16.95±1.15 mm in preterm infants at 17.3±13.2 months and 43.5±5.9 weeks PMA, respectively. In preterm infants, PMA and birth weight showed a strong independent positive association with axial length. In term infants, only PMA showed a strongly independent positive association with axial length. Collinearity diagnostics indicated no evidence of significant multicollinearity in either group. Preterm eyes had a steeper slope compared with term eyes (0.16 vs 0.02).
Conclusions:
The steeper axial elongation in preterm infants may represent compensatory postnatal growth and is clinically important for the assessment of glaucoma in the preterm period. The derived growth references offer practical clinical tools for distinguishing physiological ocular growth from pathological enlargement due to elevated intraocular pressure in neonatal-onset glaucoma.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
